Your fact-checks will appear here
Guideline updates on prostate cancer diagnostics from urology sources.
Benign prostatic hyperplasia () is common with age and causes lower urinary tract symptoms; evidence-based medical (pharmacologic) treatments most commonly used are , , combination therapy, , antimusc...
PSA density calculated from MRI-derived prostate volume (MRI‑PSAD or mPSAD) generally outperforms PSAD derived from transrectal ultrasound (TRUS‑PSAD) for predicting clinically significant prostate ca...
A modest but consistent body of retrospective and prospective studies finds that administering a immediately before prostate mpMRI reduces rectal gas and gas‑related susceptibility artifacts and is as...
(PSADT) is derived from the slope of the log-transformed PSA values over time and is conventionally calculated as ln divided by that slope; clinical calculators implement this log‑slope method and equ...
and can cause measurable rises in prostate‑specific antigen (PSA) even after the prostate has been removed, primarily by causing inflammation or infection that increases PSA leakage from residual pros...
Large prospective analyses find a modest inverse association between higher ejaculation frequency and subsequent prostate cancer diagnosis, with signals that the protective association appears across ...